These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7759395)

  • 1. Concentrations of OPC-17116, a new fluoroquinolone antibacterial, in serum and lung compartments.
    Cook PJ; Andrews JM; Wise R; Honeybourne D; Moudgil H
    J Antimicrob Chemother; 1995 Feb; 35(2):317-26. PubMed ID: 7759395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The distribution of temafloxacin in bronchial epithelial lining fluid, alveolar macrophages and bronchial mucosa.
    Baldwin DR; Wise R; Andrews JM; Ashby JP; Honeybourne D
    Eur Respir J; 1992 Apr; 5(4):471-6. PubMed ID: 1314193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penetration of sparfloxacin and ciprofloxacin into alveolar macrophages, epithelial lining fluid, and polymorphonuclear leucocytes.
    Schüler P; Zemper K; Borner K; Koeppe P; Schaberg T; Lode H
    Eur Respir J; 1997 May; 10(5):1130-6. PubMed ID: 9163658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The penetration of rufloxacin into sites of potential infection in the respiratory tract.
    Wise R; Andrews J; Imbimbo BP; Greaves I; Honeybourne D
    J Antimicrob Chemother; 1993 Dec; 32(6):861-6. PubMed ID: 8144426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative penetration of selected fluoroquinolones into respiratory tract fluids and tissues.
    Wise R
    Am J Med; 1991 Dec; 91(6A):67S-70S. PubMed ID: 1662897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative bronchoalveolar concentrations of ciprofloxacin and lomefloxacin following oral administration.
    Baldwin DR; Wise R; Andrews JM; Gill M; Honeybourne D
    Respir Med; 1993 Nov; 87(8):595-601. PubMed ID: 8290743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentration of amoxycillin and clavulanate in lung compartments in adults without pulmonary infection.
    Cook PJ; Andrews JM; Woodcock J; Wise R; Honeybourne D
    Thorax; 1994 Nov; 49(11):1134-8. PubMed ID: 7831630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentration of enrofloxacin and its active metabolite in alveolar macrophages and pulmonary epithelial lining fluid of dogs.
    Hawkins EC; Boothe DM; Guinn A; Aucoin DP; Ngyuen J
    J Vet Pharmacol Ther; 1998 Feb; 21(1):18-23. PubMed ID: 9507453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of cefdinir, a third generation cephalosporin antibiotic, in serum and pulmonary compartments.
    Cook PJ; Andrews JM; Wise R; Honeybourne D
    J Antimicrob Chemother; 1996 Feb; 37(2):331-9. PubMed ID: 8707743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The concentrations of clinafloxacin in alveolar macrophages, epithelial lining fluid, bronchial mucosa and serum after administration of single 200 mg oral doses to patients undergoing fibre-optic bronchoscopy.
    Honeybourne D; Andrews JM; Cunningham B; Jevons G; Wise R
    J Antimicrob Chemother; 1999 Jan; 43(1):153-5. PubMed ID: 10381116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of OPC-17116 against important pathogens that cause respiratory tract infections.
    Wakebe H; Imada T; Yoneda H; Mukai F; Ohguro K; Ohmori K; Tamaoka H; Yabuuchi Y
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2340-5. PubMed ID: 7840567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentrations of trovafloxacin in bronchial mucosa, epithelial lining fluid, alveolar macrophages and serum after administration of single or multiple oral doses to patients undergoing fibre-optic bronchoscopy.
    Andrews JM; Honeybourne D; Brenwald NP; Bannerjee D; Iredale M; Cunningham B; Wise R
    J Antimicrob Chemother; 1997 Jun; 39(6):797-802. PubMed ID: 9222050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative pharmacokinetic disposition of fluoroquinolones in the lung.
    Wise R; Baldwin DR; Andrews JM; Honeybourne D
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():65-71. PubMed ID: 1664831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of OPC-17116, a new fluoroquinolone, in human alveolar macrophages and other biological matrices by high performance liquid chromatography (HPLC).
    Woodcock JM; Andrews JM; Honeybourne D; Wise R
    FEMS Microbiol Lett; 1994 Jun; 119(3):315-20. PubMed ID: 8050712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentrations of garenoxacin in plasma, bronchial mucosa, alveolar macrophages and epithelial lining fluid following a single oral 600 mg dose in healthy adult subjects.
    Andrews J; Honeybourne D; Jevons G; Boyce M; Wise R; Bello A; Gajjar D
    J Antimicrob Chemother; 2003 Mar; 51(3):727-30. PubMed ID: 12615879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrapulmonary concentrations of antimicrobial agents.
    Nix DE
    Infect Dis Clin North Am; 1998 Sep; 12(3):631-46, viii. PubMed ID: 9779382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution characteristics of orally administered olamufloxacin, a newly synthesized fluoroquinolone antibacterial, in lung epithelial lining fluid and alveolar macrophage in rats.
    Sun J; Deguchi Y; Tauchi Y; He Z; Cheng G; Morimoto K
    Eur J Pharm Biopharm; 2006 Oct; 64(2):238-45. PubMed ID: 16875808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of gatifloxacin after a single oral dose in healthy young adult subjects and adult patients with chronic bronchitis, with a comparison of drug concentrations obtained by bronchoscopic microsampling and bronchoalveolar lavage.
    Kikuchi J; Yamazaki K; Kikuchi E; Ishizaka A; Nishimura M
    Clin Ther; 2007 Jan; 29(1):123-30. PubMed ID: 17379052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentrations of gatifloxacin in plasma and pulmonary compartments following a single 400 mg oral dose in patients undergoing fibre-optic bronchoscopy.
    Honeybourne D; Banerjee D; Andrews J; Wise R
    J Antimicrob Chemother; 2001 Jul; 48(1):63-6. PubMed ID: 11418513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with OPC-17116 in the treatment of gynaecological infections and its penetration into gynaecological tissues. Japanese Collaborative Study Group of OPC-17116 in Gynaecology.
    Matsuda S
    Drugs; 1995; 49 Suppl 2():395-8. PubMed ID: 8549375
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.